Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.

Source:http://linkedlifedata.com/resource/pubmed/id/15361374

Download in:

View as

General Info

PMID
15361374